Schonfeld Strategic Advisors LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 143 filers reported holding SAGE THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,663,443
+172.0%
129,419
+521.5%
0.02%
+162.5%
Q2 2023$979,097
+72.6%
20,823
+40.0%
0.01%
+60.0%
Q4 2022$567,218
+57.6%
14,872
+61.6%
0.01%
+66.7%
Q3 2022$360,000
-34.8%
9,204
-44.8%
0.00%
-40.0%
Q1 2022$552,000
-51.9%
16,680
+8.8%
0.01%
-64.3%
Q1 2021$1,147,000
-31.2%
15,333
-61.8%
0.01%
-36.4%
Q2 2020$1,668,000
+658.2%
40,100
+422.9%
0.02%
+57.1%
Q1 2020$220,000
-14.4%
7,669
+115.5%
0.01%
+133.3%
Q4 2019$257,000
-88.8%
3,558
-78.3%
0.01%
-91.2%
Q3 2019$2,300,000
+83.0%
16,400
+84.3%
0.07%
+21.4%
Q3 2018$1,257,000
+83.8%
8,900
+3.7%
0.06%
-21.1%
Q2 2017$684,000
-51.4%
8,586
-71.9%
0.07%
-70.3%
Q3 2016$1,408,000
+367.8%
30,567
+205.7%
0.24%
+256.7%
Q2 2016$301,000
-17.8%
10,000
-12.4%
0.07%
-55.0%
Q1 2016$366,00011,4190.15%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,966,688$120,204,00010.81%
Integral Health Asset Management, LLC 230,000$14,058,0004.30%
Asymmetry Capital Management, L.P. 102,462$6,262,0004.02%
ACUTA CAPITAL PARTNERS, LLC 225,000$13,752,0003.74%
DAFNA Capital Management LLC 158,306$9,676,0003.14%
Bain Capital Life Sciences Investors, LLC 499,100$30,505,0002.84%
Boxer Capital, LLC 1,094,000$66,865,0002.31%
Palo Alto Investors LP 590,200$36,073,0001.98%
Logos Global Management LP 250,000$15,280,0001.96%
Bellevue Group AG 1,579,504$96,539,0001.33%
View complete list of SAGE THERAPEUTICS INC shareholders